EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer

Treatment of ovarian cancer beyond chemotherapy: Are we hitting the target?

(2014) Álvaro Henrique Ingles Garces et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

EGCG Enhances the Efficacy of Cisplatin by Downregulating hsa-miR-98-5p in NSCLC A549 Cells

(2014) Dong-Hu Zhou et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy

(2013) Elena Lecumberri et al.   CLINICAL NUTRITION

Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway

(2013) Sang Hyuk Lee et al.   EUROPEAN JOURNAL OF CANCER

Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and Sulforaphane

(2013) Huaping Chen et al.   Journal of Oncology

Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization

(2012) Min Shen et al.   Anti-Cancer Agents in Medicinal Chemistry

An All-Atom Model of the Structure of Human Copper Transporter 1

(2012) Igor F. Tsigelny et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents

(2012) Z. D. Liang et al.   MOLECULAR CANCER THERAPEUTICS

Green Tea Polyphenols as Proteasome Inhibitors: Implication in Chemoprevention

(2011) H. Yang et al.   CURRENT CANCER DRUG TARGETS

Evaluation of renal protective effects of the green-tea (EGCG) and red grape resveratrol: role of oxidative stress and inflammatory cytokines

(2011) A.M. El-Mowafy et al.   NATURAL PRODUCT RESEARCH

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions

(2010) Giuliano Ciarimboli et al.   AMERICAN JOURNAL OF PATHOLOGY

Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator

(2010) Seiko Ishida et al.   CANCER CELL

Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats

(2010) Kazim Sahin et al.   LIFE SCIENCES

Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells

(2010) B. G. Blair et al.   MOLECULAR PHARMACOLOGY

Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo

(2010) B. G. Blair et al.   MOLECULAR PHARMACOLOGY

Novel chemotherapeutic and renal protective effects for the green tea (EGCG): Role of oxidative stress and inflammatory-cytokine signaling

(2010) A.M. El-Mowafy et al.   PHYTOMEDICINE

Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin

(2009) B. G. Blair et al.   CLINICAL CANCER RESEARCH

Enhanced Delivery of Cisplatin to Intraperitoneal Ovarian Carcinomas Mediated by the Effects of Bortezomib on the Human Copper Transporter 1

(2009) D. D. Jandial et al.   CLINICAL CANCER RESEARCH

Copper-dependent Recycling of hCTR1, the Human High Affinity Copper Transporter

(2009) Shannon A. Molloy et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines

(2008) Paul Noordhuis et al.   BIOCHEMICAL PHARMACOLOGY

Effects of the loss of Atox1 on the cellular pharmacology of cisplatin

(2008) Roohangiz Safaei et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin

(2008) Amal Shervington et al.   MOLECULAR BIOLOGY REPORTS

The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs

(2008) C. A. Larson et al.   MOLECULAR PHARMACOLOGY

Transcription Factor Sp1 Plays an Important Role in the Regulation of Copper Homeostasis in Mammalian Cells

(2008) I.-S. Song et al.   MOLECULAR PHARMACOLOGY

The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy

(2007) Matthew D. Hall et al.   Annual Review of Pharmacology and Toxicology